Determining	VBG
the	DT
True	JJ
Selectivity	NN
Profile	NNP
of	IN
av	NNP
Integrin	NNP
Ligands	NNPS
Using	VBG
Radioligand	NN
Binding	NN
:	:
Applying	VBG
an	DT
Old	JJ
Solution	NN
to	TO
a	DT
New	NNP
Problem	NNP
.	.

The	DT
arginyl-glycinyl-aspartic	JJ
acid	NN
(	(
RGD	NN
)	)
integrin	NN
subfamily	NN
contains	VBZ
five	CD
members	NNS
that	WDT
partner	NN
with	IN
the	DT
av	NN
subunit	NN
:	:
avb1	NN
,	,
avb3	NN
,	,
avb5	NN
,	,
avb6	NN
,	,
and	CC
avb8	NN
.	.

Within	IN
the	DT
av	NN
integrins	NNS
,	,
the	DT
epithelially	RB
restricted	JJ
avb6	NN
has	VBZ
been	VBN
identified	VBN
as	IN
playing	VBG
a	DT
key	JJ
role	NN
in	IN
the	DT
activation	NN
of	IN
transforming-growth-factor-b	NN
that	WDT
is	VBZ
hypothesized	VBN
to	TO
be	VB
pivotal	JJ
in	IN
the	DT
development	NN
of	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
.	.

As	IN
part	NN
of	IN
a	DT
drug	NN
discovery	NN
program	NN
to	TO
identify	VB
a	DT
selective	JJ
avb6	NN
RGD	NN
mimetic	JJ
for	IN
IPF	NN
,	,
cell	NN
adhesion	NN
and	CC
radioligand	NN
binding	NN
assays	NNS
were	VBD
investigated	VBN
to	TO
screen	VB
compounds	NNS
to	TO
determine	VB
affinity	NN
and	CC
av	NN
integrin	NN
selectivity	NN
.	.

In	IN
this	DT
study	NN
,	,
a	DT
pan-av	JJ
radioligand	NN
was	VBD
characterized	VBN
against	IN
all	PDT
the	DT
av	NN
integrins	NNS
and	CC
used	VBN
to	TO
determine	VB
accurate	JJ
selectivity	NN
profiles	NNS
for	IN
literature	NN
and	CC
novel	JJ
RGD	NN
ligands	NNS
,	,
as	RB
well	RB
as	IN
enable	VB
an	DT
early	JJ
readout	NN
on	IN
avb6	NN
dissociation	NN
kinetics	NN
.	.

It	PRP
has	VBZ
been	VBN
shown	VBN
that	IN
while	IN
cell	NN
adhesion	NN
offers	VBZ
a	DT
high	JJ
throughput	NN
and	CC
reliable	JJ
format	NN
for	IN
ranking	JJ
compounds	NNS
,	,
there	EX
are	VBP
downsides	NNS
to	TO
this	DT
format	NN
when	WRB
comparing	VBG
selectivity	NN
across	IN
av	NN
integrins	NNS
.	.

By	IN
accurately	RB
defining	VBG
the	DT
relationship	NN
between	IN
these	DT
assay	NN
formats	NNS
,	,
a	DT
medicinal	JJ
chemistry	NN
effort	NN
has	VBZ
identified	VBN
novel	JJ
,	,
high-affinity	JJ
,	,
and	CC
selective	JJ
avb6	NN
RGD	NN
mimetics	NNS
with	IN
slow	JJ
dissociation	NN
kinetics	NN
,	,
with	IN
the	DT
potential	JJ
to	TO
be	VB
developed	VBN
into	IN
clinical	JJ
candidates	NNS
for	IN
IPF	NN
.	.

